Literature DB >> 9413375

The inflammatory response to vascular surgery-associated ischaemia and reperfusion in man: effect on postoperative pulmonary function.

A B Groeneveld1, P G Raijmakers, J A Rauwerda, C E Hack.   

Abstract

OBJECTIVES: To characterise the inflammatory response to vascular surgery and ischaemia/reperfusion (I/R) in man, regarding release of inflammatory mediators, recruitment and activation of neutrophils, and their relation to postoperative pulmonary function.
DESIGN: Prospective cohort study.
MATERIALS AND METHODS: Circulating neutrophil counts and plasma levels of elastase-alpha 1-antitrypsin (AT), a neutrophil degranulation product, were measured before and approx. 2.5 h (group 1, n = 19) after elective abdominal aortic surgery, and approx. 2.9 h after elective peripheral vascular surgery (group 2, n = 6), together with concentrations of neutrophil agonists, including activated complement (C3a), secretory phospholipase A2 (sPLA2), tumor necrosis factor (TNF-alpha), interleukin (IL)-6, IL-8 and granulocyte colony-stimulating factor (G-CSF). At the time of blood sampling, respiratory variables allowing computation of the lung injury score (LIS) were obtained in patients admitted after surgery in the intensive care unit (ICU), i.e. all group 1 patients and one group 2 patient.
RESULTS: Median (range) neutrophil counts rose by 80% (-28-208) and 90% (10-147) in groups 1 and 2, respectively (n.s. between groups). The increase (p < 0.05) in elastase-alpha 1-AT level was 121% (-5-439) in group 1 and 82% (18-792) in group 2 (n.s. between groups). There was a rise (p < 0.05) in C3a level by 93% (-42-751) and of sPLA2 level by 68% (-40-1400) after surgery for the groups together (n.s. between groups), and the rise of the elastase-alpha 1-AT related to that of the C3a levels. IL-6 and G-CSF concentrations increased more in group 1 than 2. The IL-8 concentration increased in group 1 only, and TNF-alpha was unchanged in all groups. In ICU patients, the LIS related to the postoperative rise in IL-6 level only, even though the rise in plasma concentrations of cytokines interrelated. No patient developed ARDS and all survived.
CONCLUSIONS: Vascular surgery and I/R in man activates complement, releases cytokines (except for TNF-alpha), and induces neutrophil recruitment and degranulation, which may primarily depend on complement activation. In contrast to the latter, the release of cytokines may depend on the extent of I/R and may contribute to transient pulmonary dysfunction after extensive I/R.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413375     DOI: 10.1016/s1078-5884(97)80284-5

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  21 in total

1.  Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes.

Authors:  Alyssa D Gregory; Benjamin J Capoccia; Jill R Woloszynek; Daniel C Link
Journal:  J Leukoc Biol       Date:  2010-03-30       Impact factor: 4.962

Review 2.  Therapeutic targeting of acute lung injury and acute respiratory distress syndrome.

Authors:  Theodore J Standiford; Peter A Ward
Journal:  Transl Res       Date:  2015-05-05       Impact factor: 7.012

3.  Bactericidal/permeability-increasing protein attenuates systemic inflammation and acute lung injury in porcine lower limb ischemia-reperfusion injury.

Authors:  D W Harkin; A A Barros D'Sa; K McCallion; M Hoper; M I Halliday; F C Campbell
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

Review 4.  Concept of the aortic aneurysm repair-related surgical stress: a review of the literature.

Authors:  Demetrios N Moris; Michalis I Kontos; Eleftherios I Mantonakis; Antonios K Athanasiou; Eleftherios D Spartalis; Chris N Bakoyiannis; George P Chrousos; Sotirios E Georgopoulos
Journal:  Int J Clin Exp Med       Date:  2014-09-15

5.  Pleomorphic carcinoma of the lung producing granulocyte colony-stimulating factor: report of a case.

Authors:  Hironobu Wada; Shigetoshi Yoshida; Fumihiro Ishibashi; Teruaki Mizobuchi; Yasumitsu Moriya; Hidehisa Hoshino; Tatsuro Okamoto; Makoto Suzuki; Kiyoshi Shibuya; Ichiro Yoshino
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

Review 6.  Perioperative myocardial infarction in non-cardiac surgery. Pathophysiology and clinical implications.

Authors:  Pietro Amedeo Modesti; Ignazio Simonetti; Giuseppe Olivo
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

7.  Respiratory function after aortic aneurysm repair: a comparison between retroperitoneal and transperitoneal approaches.

Authors:  Carlo A Volta; Enrico Ferri; Elisabetta Marangoni; Riccardo Ragazzi; Marco Verri; Valentina Alvisi; Silvia Zardi; Sara Bertacchini; Gaetano Gritti; Raffaele Alvisi
Journal:  Intensive Care Med       Date:  2003-06-26       Impact factor: 17.440

8.  Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery.

Authors:  Joost A van Hilten; Leo M G van de Watering; J Hajo van Bockel; Cornelis J H van de Velde; Job Kievit; Ronald Brand; Wilbert B van den Hout; Robert H Geelkerken; Rudi M H Roumen; Ronald M J Wesselink; Ankie W M M Koopman-van Gemert; Jan Koning; Anneke Brand
Journal:  BMJ       Date:  2004-05-13

Review 9.  Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review.

Authors:  Diamantis I Tsilimigras; Fragiska Sigala; Georgios Karaolanis; Ioannis Ntanasis-Stathopoulos; Eleftherios Spartalis; Michael Spartalis; Nikolaos Patelis; Alexandros Papalampros; Chandler Long; Demetrios Moris
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

10.  Protective effects of hyperbaric oxygen and iloprost on ischemia/reperfusion-induced lung injury in a rabbit model.

Authors:  S Bozok; G Ilhan; Y Yilmaz; Z Dökümcü; L Tumkaya; H Karamustafa; S Ozan Karakisi; S Ergene; E Sener
Journal:  Eur J Med Res       Date:  2012-06-07       Impact factor: 2.175

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.